Info

Topaz Pharmaceuticals LLC is a start-up company that plans to develop and market pediatric medicines. Its first product is expected to be ready for commercialization in 2009. Topaz is developing a topical form of ivermectin for the treatment of head lice. Near term plans of the company include the completion of the toxicology studies, IND filing and then completion of Phase I clinical studies. The company expects to develop additional indications covering other parasitic insects affecting human health. The other five companies that received funding include Lap Belt Cinch, Inc.; Wellspring Acquisitions, Inc.; Logic Explorers, Inc. dba Altosoft Corporation; TMX Interactive, Inc.; and Cogniscape, LLC.